Cargando…
Elevated frequencies of CD14(+)HLA-DR(lo/neg) MDSCs in COVID-19 patients
Background: The immune responses, hyper-inflammation or immunosuppression, may be closely related to COVID-19 progression. We aimed to evaluate the changes of frequency of CD14(+)HLA-DR(lo/neg) MDSCs, a population of cells with potent immunosuppressive capacity, in COVID-19 patients. Methods: The le...
Autores principales: | Xue, GuoHui, Jiang, Mei, Zhao, Rui, Le, AiPing, Li, JunMing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993675/ https://www.ncbi.nlm.nih.gov/pubmed/33640878 http://dx.doi.org/10.18632/aging.202571 |
Ejemplares similares
-
The CD14(+)HLA-DR(lo/neg) Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy
por: Mengos, April E., et al.
Publicado: (2019) -
Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14(+)HLA-DR(lo/neg) Cells): The Gateway to Improved Responses
por: Laborde, Rebecca R., et al.
Publicado: (2014) -
Expansion of CD10(neg) neutrophils and CD14(+)HLA-DR(neg/low) monocytes driving proinflammatory responses in patients with acute myocardial infarction
por: Fraccarollo, Daniela, et al.
Publicado: (2021) -
Increased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patients
por: Hingorani, Pooja, et al.
Publicado: (2015) -
Expression profiling of suppressive monocytes (CD14+HLA-DRlow/neg) in cancer patients
por: Cordes, Stefan F, et al.
Publicado: (2013)